Amphomycin inhibits mannosylphosphoryldolichol synthesis by forming a complex with dolichylmonophosphate

D K Banerjee1

  • 1Department of Biochemistry and Nutrition, School of Medicine, University of Puerto Rico, San Juan 00936-5067.

Insights

The antibiotic amphomycin inhibits mannosylphosphoryldolichol biosynthesis by binding to dolichylmonophosphate (Dol-P) at the active site. This interaction reduces enzyme activity, impacting lipid biosynthesis pathways.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Metabolism

Background:

  • Mannosylphosphoryldolichol (MPD) is crucial for N-linked glycosylation in eukaryotes.
  • Amphomycin is a lipopeptide antibiotic known to affect cell wall synthesis in bacteria.
  • The precise mechanism of amphomycin's inhibitory action on eukaryotic lipid biosynthesis remains to be fully elucidated.

Purpose of the Study:

  • To investigate the inhibitory mechanism of amphomycin on mannosylphosphoryldolichol (MPD) biosynthesis in calf brain membranes.
  • To determine the interaction site and kinetics of amphomycin's effect on MPD synthase.

Main Methods:

  • Enzyme kinetics assays using GDP-mannose and dolichylmonophosphate (Dol-P) as substrates.
  • Analysis of substrate-velocity curves in the presence and absence of amphomycin.
  • Complex formation studies using radiolabeled amphomycin and various lipid phosphates/alcohols.

Main Results:

  • Amphomycin significantly reduced the Vmax of MPD biosynthesis but did not alter the Km for GDP-mannose.
  • Amphomycin induced a sigmoidal substrate-velocity curve for Dol-P, increasing the Km and altering the Hill coefficient.
  • Amphomycin selectively formed a Ca2+-dependent complex with Dol-P (and undecaprenylmonophosphate), but not with pyrophosphates or free alcohols.

Conclusions:

  • Amphomycin directly interacts with the active site of dolichylmonophosphate (Dol-P), a key glycosyl-carrier lipid.
  • This interaction competitively inhibits the enzyme mannosylphosphoryldolichol synthase, thereby blocking MPD biosynthesis.
  • The findings provide a molecular basis for amphomycin's inhibitory effects on essential glycosylation pathways.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...